Regenyx Medical

Company Overview

Snapshot

Founded in November 2016 by Yaron Rapaport and Prof. Hanna Rapaport, Regenyx Medical operates with 1-10 employees. The company has raised $3.4M across three funding rounds from two investors. In June 2025, Regenyx Medical was selected for the MedTech Innovator and ASPS Top 5 Innovation Track.

Business overview

Regenyx Medical specializes in redefining minimally invasive soft tissue restoration, a critical area within plastic and reconstructive surgery. The company's core product, Lipogenyx, is a next-generation fat grafting solution designed to enhance graft survival and integration, leading to natural-looking, lasting, and predictable results in reconstructive and aesthetic procedures. Built on proprietary synthetic peptide hydrogel technology, Lipogenyx aims to eliminate the need for revision fat grafting procedures and improve physician efficiency and patient satisfaction. Regenyx Medical operates within the Health Tech & Life Sciences sector, specifically focusing on Biomaterials & Tissue Engineering and Drug Delivery, serving healthcare providers and patients globally.

Strategic signal

Regenyx Medical's selection for the 2025 MedTech Innovator and ASPS Top 5 Innovation Track in June 2025 signals significant industry validation for its Lipogenyx product. This recognition highlights the potential of their matrix-enhanced fat grafting technology to address critical needs in soft tissue restoration, suggesting strong market relevance and a promising trajectory as the company prepares for its first clinical study and U.S. operations.

Company Intelligence Q&A

What is Regenyx Medical's primary focus?

Regenyx Medical is focused on redefining minimally invasive soft tissue restoration, particularly through its matrix-enhanced fat grafting technology.

What is Lipogenyx?

Lipogenyx is Regenyx Medical's lead product, a fat viability extender that enhances graft survival and integration for reconstructive and aesthetic procedures, built on proprietary synthetic peptide hydrogel technology.

When was Regenyx Medical selected for the MedTech Innovator program?

In June 2025, Regenyx Medical was selected for the MedTech Innovator and ASPS Top 5 Innovation Track.

Who founded Regenyx Medical?

Regenyx Medical was founded by Yaron Rapaport and Prof. Hanna Rapaport in November 2016.

What was a notable early recognition for the company?

In May 2019, Bone Sci Bio (an earlier name for Regenyx Medical) presented breakthrough solutions for bone healing, as reported by BGU.ac.il.